NASDAQ: RNAAvidity Biosciences Inc Stock Ownership - Who owns Avidity Biosciences?
Insider buying vs selling
Have Avidity Biosciences Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Arthur A. Levin | Director | 2024-04-19 | 5,000 | $1.24 | $6.20kBuy |
| Arthur A. Levin | Director | 2024-04-19 | 5,000 | $22.83 | $114.13kSell |
| Arthur A. Levin | Director | 2024-04-03 | 20,000 | $27.11 | $542.22kSell |
| Sarah Boyce | President and CEO | 2024-04-02 | 28,000 | $1.24 | $34.72kBuy |
| Sarah Boyce | President and CEO | 2024-04-02 | 28,000 | $26.25 | $734.92kSell |
| Arthur A. Levin | Director | 2024-03-19 | 5,000 | $23.97 | $119.85kSell |
| Arthur A. Levin | Director | 2024-03-19 | 5,000 | $1.24 | $6.20kBuy |
| Michael F. MacLean | Chief Financial Officer | 2024-03-13 | 40,000 | $8.82 | $352.80kBuy |
| Michael F. MacLean | Chief Financial Officer | 2024-03-13 | 40,000 | $24.52 | $980.76kSell |
| Arthur A. Levin | Director | 2024-03-12 | 25,000 | $1.24 | $31.00kBuy |
RNA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when RNA insiders and whales buy or sell their stock.
RNA Shareholders
What type of owners hold Avidity Biosciences Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Fmr LLC | 13.05% | 10,404,096 | $236.49M | Institution |
| Rtw Investments LP | 11.03% | 8,790,000 | $199.80M | Insider |
| Price T Rowe Associates Inc | 8.67% | 6,912,661 | $157.12M | Institution |
| Rtw Investments LP | 8.39% | 6,689,789 | $152.06M | Institution |
| Blackrock Inc | 8.15% | 6,496,593 | $147.67M | Institution |
| Cowen And Company LLC | 7.06% | 5,629,103 | $127.95M | Institution |
| Vanguard Group Inc | 5.07% | 4,043,179 | $91.90M | Institution |
| State Street Corp | 4.31% | 3,438,328 | $78.15M | Institution |
| Cormorant Asset Management LP | 3.15% | 2,514,545 | $57.16M | Insider |
| Avoro Capital Advisors LLC | 3.15% | 2,510,000 | $57.05M | Institution |
RNA vs Biotech Stocks
Avidity Biosciences Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.